TREA

79334635 - OLIX

Follow

Information

  • Trademark
  • 79334635
  • Serial Number
    79334635
  • Registration Number
    7435162
  • Filing Date
    December 24, 2021
    3 years ago
  • Registration Date
    July 09, 2024
    5 months ago
  • Transaction Date
    December 14, 2024
    20 days ago
  • Status Date
    July 09, 2024
    5 months ago
  • Published for Opposition Date
    April 23, 2024
    8 months ago
  • Location Date
    July 08, 2024
    5 months ago
  • Status Code
    700
  • Current Location
    FILE REPOSITORY (FRANCONIA)
    Employee Name
    CLARKE, NANCY
  • Attorney Docket Number
    YPLE040.001I
    Attorney Name
    Joesph A. R. Gerber
  • Owners
Information
Mark Drawing Code
4
Mark Identification
OLIX
Case File Statements
  • GS0051: Dietary supplements; nucleic acid sequences for medical purposes; cultures of microorganisms for medical use; biotechnological preparations for medical use, namely, cells, recombinant DNA sequences, synthetic RNA sequences, and oligonucleotides for use in treating and repairing damaged human tissue through tissue nanotransfection (TNT); reagent paper for medical purposes; drugs for medical purposes, namely, cardiovascular pharmaceuticals, anti-diabetic pharmaceuticals, metabolic pharmaceuticals, antibacterial pharmaceuticals, macular degeneration treatment pharmaceuticals (or ophthalmic pharmaceuticals), hair loss treatment pharmaceuticals, hepatitis treatment pharmaceuticals, respiratory disease treatment pharmaceuticals, neurological disease treatment pharmaceuticals, hepatological disease treatment pharmaceuticals; synthetic peptides for the treatment of metabolic, ophthalmic, cardiovascular, pulmonary, hepatological, respiratory, neurological diseases and disorders; cardiovascular pharmaceuticals, anti-diabetic pharmaceuticals, antibacterial pharmaceuticals, macular degeneration treatment pharmaceuticals (or ophthalmic pharmaceuticals), hair loss treatment pharmaceuticals, hepatitis treatment pharmaceuticals, respiratory disease treatment pharmaceuticals, neurological disease treatment pharmaceuticals, hepatological disease treatment pharmaceuticals; materials for dental fillings; colostral antibodies for medical purposes, monoclonal antibodies for medical purposes, hybrid antibodies for medical purposes; all the foregoing for human use and excluding goods related to the care and feeding of animals and plants
  • GS0421: Product research and development in the field of biotech technology; scientific research in the field of biotechnology, medical research in the field of biotechnology; scientific research and scientific investigations for medical purposes in the field of biomedicine; scientific research consultation and providing scientific research information both of the foregoing in the field of biomedicine; bacteriological research; scientific research for medical purposes in the area of cancerous diseases; development of pharmaceutical preparations and medicines; pharmaceutical research services; scientific research in the field of genetics; medical research laboratory services; Scientific research and scientific investigations for medical purposes, both of the foregoing in the fields of medicine, health and pharmacology; medical research; All the above-mentioned services excluding services related to the care and feeding of animals and plants
Case File Event Statements
  • 3/3/2022 - 2 years ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR
  • 3/10/2022 - 2 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 3/15/2022 - 2 years ago
    3 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 7/23/2022 - 2 years ago
    4 - CORRECTION TRANSACTION RECEIVED FROM IB Type: CRCV
  • 9/28/2022 - 2 years ago
    5 - ASSIGNED TO EXAMINER Type: DOCK
  • 9/28/2022 - 2 years ago
    6 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 9/29/2022 - 2 years ago
    7 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 10/1/2022 - 2 years ago
    8 - LIMITATION OF GOODS RECEIVED FROM IB Type: LIMG
  • 10/28/2022 - 2 years ago
    9 - CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED Type: CREV
  • 12/12/2022 - 2 years ago
    10 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 12/12/2022 - 2 years ago
    11 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 1/4/2023 - 2 years ago
    12 - REFUSAL PROCESSED BY IB Type: RFNT
  • 1/12/2023 - a year ago
    13 - LIMITATION FROM THE IB - REQUEST EXAM REVIEW Type: LIME
  • 2/1/2023 - a year ago
    14 - ATTORNEY REVIEW COMPLETED Type: ATRV
  • 5/2/2023 - a year ago
    15 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 5/2/2023 - a year ago
    16 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 5/3/2023 - a year ago
    17 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 5/24/2023 - a year ago
    18 - FINAL REFUSAL WRITTEN Type: CNFR
  • 5/24/2023 - a year ago
    19 - FINAL REFUSAL E-MAILED Type: GNFR
  • 5/24/2023 - a year ago
    20 - NOTIFICATION OF FINAL REFUSAL EMAILED Type: GNFN
  • 11/21/2023 - a year ago
    21 - TEAS REQUEST FOR RECONSIDERATION RECEIVED Type: ERFR
  • 11/21/2023 - a year ago
    22 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 11/22/2023 - a year ago
    23 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 12/27/2023 - a year ago
    24 - NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB Type: OPNR
  • 12/27/2023 - a year ago
    25 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 1/8/2024 - 12 months ago
    26 - ACTION CONTINUING A FINAL - COMPLETED Type: CNCF
  • 1/8/2024 - 12 months ago
    27 - CONTINUATION OF FINAL REFUSAL E-MAILED Type: GNCF
  • 1/8/2024 - 12 months ago
    28 - NOTIFICATION OF SUBSEQUENT FINAL EMAILED Type: GNS1
  • 1/13/2024 - 11 months ago
    29 - NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB Type: OPNX
  • 2/6/2024 - 11 months ago
    30 - TEAS REQUEST FOR RECONSIDERATION RECEIVED Type: ERFR
  • 2/6/2024 - 11 months ago
    31 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 2/7/2024 - 11 months ago
    32 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 3/12/2024 - 9 months ago
    33 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 4/3/2024 - 9 months ago
    34 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 4/10/2024 - 8 months ago
    36 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 4/10/2024 - 8 months ago
    35 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R
  • 4/23/2024 - 8 months ago
    37 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 7/9/2024 - 5 months ago
    40 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 4/23/2024 - 8 months ago
    38 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 4/29/2024 - 8 months ago
    39 - NOTIFICATION PROCESSED BY IB Type: GPNX
  • 7/9/2024 - 5 months ago
    41 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC
  • 10/9/2024 - 2 months ago
    42 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR
  • 12/13/2024 - 21 days ago
    43 - FINAL DISPOSITION PROCESSED Type: FIMP
  • 12/13/2024 - 21 days ago
    44 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS